Publicaciones en colaboración con investigadores/as de University of Erlangen-Nuremberg (26)

2024

  1. Intestinal inflammation marker calprotectin regulates epithelial intestinal zinc metabolism and proliferation in mouse jejunal organoids

    Biomedicine and Pharmacotherapy, Vol. 174

2023

  1. Corrigendum: Position statement and updated international guideline for safe and effective whole-body electromyostimulation training-the need for common sense in WB-EMS application (Frontiers in Physiology, (2023), 14, (1174103), 10.3389/fphys.2023.1174103)

    Frontiers in Physiology

  2. Position statement and updated international guideline for safe and effective whole-body electromyostimulation training-the need for common sense in WB-EMS application

    Frontiers in Physiology, Vol. 14

2022

  1. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

    npj Genomic Medicine, Vol. 7, Núm. 1

  2. The Use of Human Biomonitoring to Assess Occupational Exposure to PAHs in Europe: A Comprehensive Review

    Toxics, Vol. 10, Núm. 8

2021

  1. Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy

    Journal of Hepatology, Vol. 74, Núm. 4, pp. 801-810

2020

  1. A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications, Vol. 10, Núm. 1

  2. Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course

    Journal of Clinical Medicine, Vol. 8, Núm. 11

2017

  1. Analysis of ATP8B4 F436L Missense Variant in a Large Systemic Sclerosis Cohort

    Arthritis and Rheumatology, Vol. 69, Núm. 6, pp. 1337-1338

  2. Inflammatory pain control by blocking oxidized phospholipid-mediated TRP channel activation

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies

    Arthritis and Rheumatology, Vol. 68, Núm. 9, pp. 2338-2344

  2. Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 8, pp. 1521-1526

2015

  1. Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis

    Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35

2014

  1. A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility

    Arthritis Research and Therapy, Vol. 16, Núm. 1

  2. Bupivacaine-induced cellular entry of QX-314 and its contribution to differential nerve block

    British Journal of Pharmacology, Vol. 171, Núm. 2, pp. 438-451

  3. Identification of IL12RB1 as a Novel Systemic Sclerosis Susceptibility Locus

    Arthritis and Rheumatology

2013

  1. Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 7, pp. 1233-1238

  2. New insight on the Xq28 association with systemic sclerosis

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 12, pp. 2032-2038

  3. Phenotyping the function of TRPV1-expressing sensory neurons by targeted axonal silencing

    Journal of Neuroscience, Vol. 33, Núm. 1, pp. 315-326